MRP
ABBV icon

Measured Risk Portfolios’s AbbVie ABBV Stock Holding History

Measured Risk Portfolios’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.29M Buy
10,543
+984
+10% +$218K 2.51% 14
2025
Q4 		$2.18M Sell
9,559
-1,696
-15% -$386K 2.17% 16
2025
Q3 		$2.61M Buy
11,255
+206
+2% +$41.9K 2.43% 6
2025
Q2 		$2.05M Buy
11,049
+294
+3% +$54.6K 1.98% 20
2025
Q1 		$2.25M Sell
10,755
-937
-8% -$182K 2.42% 14
2024
Q4 		$2.08M Buy
+11,692
New +$2.15M 2.17% 17

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Measured Risk Portfolios's ABBV Position: Q1 2026 in Review

Measured Risk Portfolios increased its AbbVie (ABBV) stake by 10% in Q1 2026, buying an estimated $218K and bringing the position to 10,543 shares worth $2.29M. The position accounts for 2.51% of the portfolio, ranked #14.

Measured Risk Portfolios first reported a position in ABBV in Q4 2024 and has held it in 6 quarters since. The position peaked at $2.61M in Q3 2025. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Measured Risk Portfolios held 10,543 shares of AbbVie worth $2.29M as of Q1 2026.
  • Measured Risk Portfolios bought 984 AbbVie shares in Q1 2026, an estimated $218K.
  • AbbVie made up 2.51% of Measured Risk Portfolios's portfolio in Q1 2026, its #14 holding.
  • Measured Risk Portfolios first reported a position in AbbVie in Q4 2024 and has held it in 6 quarters since.
  • Measured Risk Portfolios's AbbVie position peaked at $2.61M in Q3 2025.
  • 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Measured Risk Portfolios's 13F filing for Q1 2026, filed 15 May 2026.